Delve Insight Market Research Reports

Title published price

CXCR4 Inhibitor -Pipeline Insights, 2017

By Delve Insight

DelveInsight's, "CXCR4 Inhibitor-Mechanism of action Insights, 2017", report provides comprehensive insights of the ongoing therapeutic research and development across CXCR4 Inhibitor. The report provides a complete understanding of the pipeline acti ...

01-Aug-2017 $1500

Tumor Necrosis Factor Alpha (TNF-a) Agonist -Pipeline Insights, 2017

By Delve Insight

DelveInsight's, "Tumor Necrosis Factor Alpha (TNF-a) Agonist-Mechanism of action Insights, 2017", report provides comprehensive insights of the ongoing therapeutic research and development across Tumor Necrosis Factor Alpha (TNF-a) Agonist. The repor ...

01-Aug-2017 $1250

Cyclin-Dependent Kinase Inhibitor -Pipeline Insights, 2017

By Delve Insight

DelveInsight's, "Cyclin-Dependent Kinase Inhibitor-Mechanism of action Insights, 2017", report provides comprehensive insights of the ongoing therapeutic research and development across Cyclin-Dependent Kinase Inhibitor. The report provides a complet ...

01-Aug-2017 $1250

Type 1 Lysophosphatidic Acid Receptor (LPA1) Inhibitor -Pipeline Insights, 2017

By Delve Insight

DelveInsight's, "Type 1 Lysophosphatidic Acid Receptor (LPA1) Inhibitor-Mechanism of action Insights, 2017", report provides comprehensive insights of the ongoing therapeutic research and development across Type 1 Lysophosphatidic Acid Receptor (LPA1 ...

01-Aug-2017 $1250

Cyclin-Dependent Kinase 1 (CDK1) Inhibitor -Pipeline Insights, 2017

By Delve Insight

DelveInsight's, "Cyclin-Dependent Kinase 1 (CDK1) Inhibitor-Mechanism of action Insights, 2017", report provides comprehensive insights of the ongoing therapeutic research and development across Cyclin-Dependent Kinase 1 (CDK1) Inhibitor. The report ...

01-Aug-2017 $1250

Ubiquitin conjugating enzyme Inhibitor -Pipeline Insights, 2017

By Delve Insight

DelveInsight's, "Ubiquitin conjugating enzyme Inhibitor-Mechanism of action Insights, 2017", report provides comprehensive insights of the ongoing therapeutic research and development across Ubiquitin conjugating enzyme Inhibitor. The report provides ...

01-Aug-2017 $1250

Cyclin-Dependent Kinase 2 (CDK2) Inhibitor -Pipeline Insights, 2017

By Delve Insight

DelveInsight's, "Cyclin-Dependent Kinase 2 (CDK2) Inhibitor-Mechanism of action Insights, 2017", report provides comprehensive insights of the ongoing therapeutic research and development across Cyclin-Dependent Kinase 2 (CDK2) Inhibitor. The report ...

01-Aug-2017 $1250

Ubiquitin Specific Proteases (USP) Inhibitor -Pipeline Insights, 2017

By Delve Insight

DelveInsight's, "Ubiquitin Specific Proteases (USP) Inhibitor-Mechanism of action Insights, 2017", report provides comprehensive insights of the ongoing therapeutic research and development across Ubiquitin Specific Proteases (USP) Inhibitor. The rep ...

01-Aug-2017 $1250

Cyclin-Dependent Kinase 6/4 (CDK6/4) Inhibitor -Pipeline Insights, 2017

By Delve Insight

DelveInsight's, "Cyclin-Dependent Kinase 6/4 (CDK6/4) Inhibitor-Mechanism of action Insights, 2017", report provides comprehensive insights of the ongoing therapeutic research and development across Cyclin-Dependent Kinase 6/4 (CDK6/4) Inhibitor. The ...

01-Aug-2017 $1500

Vascular Adhesion Protein 1 (VAP-1) Inhibitor -Pipeline Insights, 2017

By Delve Insight

DelveInsight's, "Vascular Adhesion Protein 1 (VAP-1) Inhibitor-Mechanism of action Insights, 2017", report provides comprehensive insights of the ongoing therapeutic research and development across Vascular Adhesion Protein 1 (VAP-1) Inhibitor. The r ...

01-Aug-2017 $1250

Cyclin-Dependent Kinase 9 (CDK9) Inhibitor -Pipeline Insights, 2017

By Delve Insight

DelveInsight's, "Cyclin-Dependent Kinase 9 (CDK9) Inhibitor-Mechanism of action Insights, 2017", report provides comprehensive insights of the ongoing therapeutic research and development across Cyclin-Dependent Kinase 9 (CDK9) Inhibitor. The report ...

01-Aug-2017 $1500

Vascular Endothelial Growth Factor Inhibitor -Pipeline Insights, 2017

By Delve Insight

DelveInsight's, "Vascular Endothelial Growth Factor Inhibitor-Mechanism of action Insights, 2017", report provides comprehensive insights of the ongoing therapeutic research and development across Vascular Endothelial Growth Factor Inhibitor. The r ...

01-Aug-2017 $1250

Cyclophilin Inhibitor -Pipeline Insights, 2017

By Delve Insight

DelveInsight's, "Cyclophilin Inhibitor-Mechanism of action Insights, 2017", report provides comprehensive insights of the ongoing therapeutic research and development across Cyclophilin Inhibitor. The report provides a complete understanding of the p ...

01-Aug-2017 $1250

Vascular Endothelial Growth Factor A (VEGF-A) Inhibitor -Pipeline Insights, 2017

By Delve Insight

DelveInsight's, "Vascular Endothelial Growth Factor A (VEGF-A) Inhibitor-Mechanism of action Insights, 2017", report provides comprehensive insights of the ongoing therapeutic research and development across Vascular Endothelial Growth Factor A (VEGF ...

01-Aug-2017 $1250

Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Inhibitor -Pipeline Insights, 2017

By Delve Insight

DelveInsight's, "Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Inhibitor-Mechanism of action Insights, 2017", report provides comprehensive insights of the ongoing therapeutic research and development across Cystic Fibrosis Transmembrane ...

01-Aug-2017 $1250

Vasopressin Receptor Antagonist -Pipeline Insights, 2017

By Delve Insight

DelveInsight's, "Vasopressin Receptor Antagonist-Mechanism of action Insights, 2017", report provides comprehensive insights of the ongoing therapeutic research and development across Vasopressin Receptor Antagonist. The report provides a complete un ...

01-Aug-2017 $1250

Cystic Fibrosis Transmembrane Conductance Regulators (CFTR) -Pipeline Insights, 2017

By Delve Insight

DelveInsight's, "Cystic Fibrosis Transmembrane Conductance Regulators (CFTR)-Mechanism of action Insights, 2017", report provides comprehensive insights of the ongoing therapeutic research and development across Cystic Fibrosis Transmembrane Conducta ...

01-Aug-2017 $1500

Vasopressin V1 Receptor (V1R) Antagonist -Pipeline Insights, 2017

By Delve Insight

DelveInsight's, "Vasopressin V1 Receptor (V1R) Antagonist-Mechanism of action Insights, 2017", report provides comprehensive insights of the ongoing therapeutic research and development across Vasopressin V1 Receptor (V1R) Antagonist. The report prov ...

01-Aug-2017 $1250

Cytochrome P450 Superfamily (CYP or CYP450) Inhibitor -Pipeline Insights, 2017

By Delve Insight

DelveInsight's, "Cytochrome P450 Superfamily (CYP or CYP450) Inhibitor-Mechanism of action Insights, 2017", report provides comprehensive insights of the ongoing therapeutic research and development across Cytochrome P450 Superfamily (CYP or CYP450) ...

01-Aug-2017 $1500

Vasopressin V2 Receptor (V2R) Agonist -Pipeline Insights, 2017

By Delve Insight

DelveInsight's, "Vasopressin V2 Receptor (V2R) Agonist-Mechanism of action Insights, 2017", report provides comprehensive insights of the ongoing therapeutic research and development across Vasopressin V2 Receptor (V2R) Agonist. The report provides a ...

01-Aug-2017 $1250